Aethlon Medical boosts authorized common shares 10x to 200M, effective Oct 7

AETHLON MEDICAL INC

Authorized common stock, $0.001 par value, rises from 20,000,000 to 200,000,000 shares, amending Article V of the Articles of Incorporation.
Stockholders approved the amendment at the 2026 Annual Meeting held October 1, 2026; Certificate of Amendment filed with the Nevada Secretary of State and effective October 7, 2026.
Filing discloses no issuance, pricing, or intended use of proceeds for the newly authorized shares, and no corresponding financing was announced.
Certificate of Amendment attached as Exhibit 3.1; filing signed October 9, 2026 by CEO and CFO James B. Frakes.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.